Thanks WBA - I had seen that buyout came into the picture in 2021 "Journey Medical Corp entered into a definitive agreement to acquire Qbrexza from Dermira, Inc. for $160 million on March 31, 2021"
But after the Dermira report in Q3 2019 Prescriptions data and the 50,000 patients quote in 2020 I'm unable find any additional prescriptions data from Journey Medical Corp. Did you find any data on prescriptions / sale figures for the 2021-2024?
BOT - Anything but charting, page-9415
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
-0.005(1.32%) |
Mkt cap ! $678.7M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 35.5¢ | $2.388M | 6.527M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 31921 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 132066 | 4 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |